An extensive polymerase chain reaction–allele‐specific polymorphism strategy for clinical ABO blood group genotyping that avoids potential errors caused by null, subgroup, and hybrid alleles
- 8 August 2007
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 47 (11) , 2110-2125
- https://doi.org/10.1111/j.1537-2995.2007.01436.x
Abstract
Background: ABO genotyping is complicated by the remarkable diversity at the ABO locus. Recombination or gene conversion between common alleles may lead to hybrids resulting in unexpected ABO phenotypes. Furthermore, numerous mutations associated with weak subgroups and nondeletional null alleles should be considered. All known ABO genotyping methods, however, risk incorrect phenotype predictions if any such alleles are present. Study Design and Methods: An extensive set of allele-specific primers was designed to accomplish hybrid-proof multiplex polymerase chain reaction (PCR) amplification of DNA fragments for detection of ABO alleles. Results were compared with serologic findings and ABO genotypes defined by previously published PCR-restriction fragment length polymorphism/PCR-allele-specific polymorphism (ASP) methods or DNA sequencing. Results: Phenotypically well-characterized samples from blood donors with common blood groups and rare-subgroup families were analyzed. In addition to the commonly encountered alleles (A(1), A(1(467C > T)), A(2), B, O-1, O-1v, and O-2), the new method can detect hybrid alleles thanks to long-range amplification across intron 6. Four of 12 PCR-ASP procedures are used to screen for multiple infrequent subgroup and null alleles. This concept allows for a low-resolution typing format in which the presence of, for example, a weak subgroup or cis-AB/B(A) is indicated but not further defined. In an optional high-resolution step, more detailed genotype information is obtained. Conclusion: A new genotyping approach has been developed and evaluated that can correctly identify ABO alleles including nondeletional null alleles, subgroups, and hybrids resulting from recombinational crossing-over events between exons 6 and 7. This approach is clinically applicable and decreases the risk for erroneous ABO phenotype prediction compared to previously published methodsKeywords
This publication has 60 references indexed in Scilit:
- Evolution of theOalleles of the human ABO blood group geneTransfusion, 2004
- Allelic genes of blood group antigens: A source of human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation DatabaseHuman Mutation, 2003
- The Molecular Basis for the B(A) Allele: An Amino Acid Alteration in the Human Histoblood Group B α-(1,3)-Galactosyltransferase Increases Its Intrinsic α-(1,3)-N-Acetylgalactosaminyltransferase ActivityBiochemical and Biophysical Research Communications, 1999
- Molecular Analysis of theOAlleles at the Blood Group ABO Locus in Populations of Different Ethnic Origin Reveals Novel Crossing-Over Events and Point MutationsBiochemical and Biophysical Research Communications, 1997
- A de novo recombination in the ABO blood group gene and evidence for the occurrence of recombination productsHuman Genetics, 1997
- An Ael Allele-Specific Nucleotide Insertion at the Blood Group ABO Locus and Its Detection Using a Sequence-Specific Polymerase Chain ReactionBiochemical and Biophysical Research Communications, 1995
- A Rapid and Simple ABO Genotype Screening Method Using a Novel B/O2 versus A/O2 Discriminating Nucleotide Substitution at the ABO LocusVox Sanguinis, 1995
- Genomic organization of human histo-blood group ABO genesGlycobiology, 1995
- Genomic Cloning of the Human Histo-Blood Group ABO LocusBiochemical and Biophysical Research Communications, 1995
- Human histo-blood group A2 transferase coded by A2 allele, one of the a subtypes, is characterized by a single base deletion in the coding sequence, which results in an additional domain at the carboxyl terminalBiochemical and Biophysical Research Communications, 1992